Summary & Overview
HCPCS L8685: Implantable Rechargeable Neurostimulator Pulse Generator
HCPCS Level II code L8685 designates an implantable, single-array, rechargeable neurostimulator pulse generator supplied with an extension. These devices are central to neuromodulation therapies for refractory chronic pain and certain neurologic disorders, representing a significant category of durable medical equipment and implantable technology used across the country. The code matters nationally because it standardizes billing for a high-cost, implantable device with implications for coverage policy and device selection.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context and typical sites of service, coverage and billing considerations commonly encountered with implantable neurostimulators, and national benchmarking topics relevant to device utilization and reimbursement pathways. The publication also highlights common modifiers and administrative elements used with this HCPCS Level II code where applicable.
This summary equips clinicians, billing professionals, and policy analysts with the essential facts about coding and service context for L8685, and points to areas where payor-specific coverage rules and reimbursement practices are commonly reviewed.
Billing Code Overview
HCPCS Level II code L8685 represents an implantable neurostimulator pulse generator, single array, rechargeable, includes extension. This device is used to deliver electrical stimulation to targeted neural structures for management of chronic pain or neurologic conditions that are responsive to neuromodulation therapy.
-
Service type: Implantable rechargeable neurostimulator system implantation and device supply
-
Typical site of service: Ambulatory surgical center or hospital outpatient setting for device implantation and programming
Clinical & Coding Specifications
Clinical Context
A 58-year-old patient with chronic, refractory neuropathic pain from failed back surgery syndrome presents for implantation of an implantable neurostimulator pulse generator. Prior conservative treatments including medications, physical therapy, and a successful trial spinal cord stimulation have been documented. The procedure is scheduled in an outpatient ambulatory surgery center or hospital operating room under monitored anesthesia care or general anesthesia. The implantable neurostimulator pulse generator (single array, rechargeable, includes extension) is implanted in a subcutaneous pocket, connected to leads tunneled or extended to the target epidural lead array. Intraoperative testing of paresthesia coverage is performed, device functionality and recharge capability are confirmed, and final wound closure is completed. Postoperative workflow includes device programming by the implanting physician or trained clinician, patient education on recharging and device management, routine wound checks, and scheduled follow-up for stimulation optimization and pain outcome assessment.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier specified (placeholder) | Use per payer instructions when no specific modifier applies and payer requires a placeholder. |
22 |